The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study.

Plain-language guide to PMID 35405355 (2022): observational study of Vitamin D, K2, Magnesium and Zinc in 60 patients, diabetic retinopathy and glaucoma.

Key Facts

PMID: 35405355
Journal: Diabetes & metabolic syndrome
Year: 2022
Study type: Observational Study
Authors: Kamel MF et al. (13 authors)
DOI: 10.1016/j.dsx.2022.102473

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in the context of diabetic retinopathy and glaucoma in this observational study publication.

The level of albuminuria is used to evaluate diabetic nephropathy (DN).

However, to detect or predict the early stages of DN, better biomarkers are needed.

An enzyme-linked immunosorbent assay was used to determine the levels of four biomarkers of DN; urinary adiponectin (ADP), urinary transferrin, serum Zinc Alpha 2 Glycoprotein (ZAG), and urinary Retinol Binding Protein (RBP).

Who Took Part

The abstract describes 60 patients taking part.

PubMed tags the participants as both men and women.

This study is a case-control observational study. 80 Egyptians participated in the study: 60 patients with type 2 diabetes mellitus (T2DM) were divided into three groups (20 patients each), and 20 healthy subjects with matched age and gender were used as controls.

How the Study Was Run

Demographic and laboratory data were analyzed.

What Was Measured

The subject headings attached to it are Adiponectin, Albuminuria, Biomarkers, Case-Control Studies, Diabetes Mellitus, Type 2, Diabetic Nephropathies and Early Diagnosis.

The authors tagged it with the keywords Diabetic nephropathy, Macro-albuminuria, Micro-albuminuria, Normo-albuminuria, RBP and Transferrin.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 60 patients in people with diabetic retinopathy and glaucoma.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2022 (Diabetes & metabolic syndrome), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Diabetic retinopathy and glaucoma research.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.